Mark Paulhamus M.S.
About Mark Paulhamus M.S.
Mark Paulhamus M.S. is a Senior Territory Business Manager at Bristol Myers Squibb, specializing in Melanoma, Large B Cell Lymphoma, and Multiple Myeloma. He has over 22 years of experience in the pharmaceutical and biotechnology industries, with a strong background in immuno-oncology and CAR-T cell therapy.
Current Title
Mark Paulhamus serves as the Senior Territory Business Manager at Bristol Myers Squibb, focusing on melanoma, large B cell lymphoma, and multiple myeloma. He operates in New Hampshire, United States, where his role involves significant interaction with healthcare providers and patients.
Previous Roles
Mark Paulhamus has held several notable positions in the pharmaceutical and biotechnology industries. Most recently, he worked at Takeda Oncology as an Oncology Territory Manager for the Lung Franchise from 2021 to 2022 in Boston, Massachusetts. Before that, he also served as an Oncology Territory Manager for Multiple Myeloma at Takeda Oncology from 2020 to 2021. At The Janssen Pharmaceutical Companies of Johnson & Johnson, he was an Executive Hospital Sales Specialist for nine years, covering NH/Southern VT/Boston North.
Teaching Experience
In addition to his roles in the pharmaceutical industry, Mark Paulhamus worked as an Adjunct Professor of Business at Rivier University from 2020 to 2023 in Nashua, New Hampshire. His experience in academia complements his extensive professional background, providing him with additional expertise in business and leadership.
Education and Certifications
Mark Paulhamus holds a Master of Science degree in Business--Organizational Leadership from Southern New Hampshire University. He also earned a B.A. in Political Science, Pre-Law from the University of New Hampshire. Additionally, he completed a Leadership and Management Certificate at Harvard Business School Online in 2022.
Industry Expertise
With over 22 years of experience in the pharmaceutical and biotechnology industries, Mark Paulhamus specializes in multiple therapeutic areas including oncology, hematology, immunology, and cardiology. He has extensive experience in CAR-T cell therapy with Breyanzi and immuno-oncology treatments like Opdualag. His robust skill set includes sales and marketing, communications, and coaching and mentoring.